In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs Multiple companies are jockeying for position in the treatment of a condition known as ATTR-CM

https://www.statnews.com/2026/08/28/astrazeneca-ionis-wainua-eplontersen-attr-cm-study-failure-bridgebio-alnylam/ By Andrew JosephAug. 28, 2026 Europe Correspondent